Stmnt re Legacy Health

NMT Group PLC
17 May 2001

May 17, 2001



New Medical Technology Announces Contract Award and Initiation of Commercial
Sales To Legacy Health System



New Medical Technology, Inc. (NMT Inc.), announced today the contract award
and initiation of commercial sales to Legacy Health System, headquartered in
Portland Oregon. Legacy Health System is a large, Integrated Healthcare
Delivery System which includes Emanuel Hospital & Health Center, Emanuel
Children's Hospital, Good Samaritan Hospital & Medical Center, Meridian Park
Hospital, Mount Hood Medical Center, a Visiting Nurse Association, the Legacy
Clinics and the CareMark/Managed HealthCare Northwest PPO.



New Medical Technology, Inc. will supply Legacy Health System with its
patented, latex-free NMT Safety Syringe. The NMT Safety Syringe features
automatic needle retraction technology that is activated as the user depresses
the plunger to inject medication.  After having been automatically retracted,
the needle is safely stored in the barrel after use, virtually eliminating
needlestick injuries. The NMT Safety Syringe will be provided in both its 3cc
size and a newly introduced 1cc size.



A commitment to conduct extensive in-servicing has been made by NMT Inc. to
ensure that the staff at Legacy Health System are properly trained and
familiarised with the NMT Safety Syringe.  In-servicing will begin on May 15
at Legacy Meridian Park Hospital and will continue to all Legacy hospitals
over the course of the next seven weeks.



It is estimated that, every day, healthcare workers in the United States
experience nearly 4,000 inadvertent needlesticks. On November 6, 2000,
President Clinton signed the Federal Needlestick Safety and Prevention Act
into law, after unanimous approval in Congress. This law mandates that health
care workers have access to safety-engineered sharps devices that provide
added protection against needlesticks and consequential disease transmission
due to bloodborne pathogens such as Hepatitis and HIV/AIDS.



Stephen J. Czick, President of NMT Inc., said: ' We are very pleased that
Legacy Health System has chosen the NMT Safety Syringe as part of its overall
strategy to prevent needlestick injuries. NMT Inc. strongly believes that the
adoption of the NMT Safety Syringe and other safety engineered devices by
forward-looking institutions such as Legacy Health System represents a strong
commitment to the protection of their employees and also demonstrates their
compliance with the Federal Needlestick Prevention and Safety Act. We believe
that the automatic needle retraction technology contained in the NMT Safety
Syringe is the ultimate in needlestick prevention and we continue to see
strong interest and evaluation of our products throughout the United States.'



Enquiries:


NMT Group PLC
Roy Smith, Chief Executive Officer                   0789 9877047
Tony Fletcher, Finance Director                      07836 725246

NMT Inc.
Steve J. Czick, President                            001 617 852 4396

Financial Dynamics
Fiona Noblet                                         020 7831 3113